In 2023, Italy's production of medicaments containing penicillins, streptomycins, or their derivatives was at 235 million euros. The forecast data from 2024 to 2028 indicates a steady increase, with values rising from 241.78 million euros in 2024 to 266.76 million euros in 2028. Year-on-year growth rates from 2024 to 2028 are modest, reflecting a consistent upward trend. The Compound Annual Growth Rate (CAGR) over this five-year forecast period is also positive, suggesting a stable market outlook.

Future trends to watch for include:

Potential market disruptions due to changes in regulations or supply chain challenges.
Advancements in pharmaceutical technology impacting production methods or costs.
Fluctuations in global demand impacting export opportunities for Italian producers.